 |
| CrossRef Text and Data Mining |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
| Management of adverse events in cancer treatment with immune checkpoint inhibitors |
| Myoung Joo Kang |
|
J Korean Med Assoc. 2021;64(5):358-365. Published online May 10, 2021 DOI: https://doi.org/10.5124/jkma.2021.64.5.358 |
|
Management of adverse events in cancer treatment with immune checkpoint inhibitors Journal of the Korean Medical Association. 2021;64(5):358-365  Safety of checkpoint inhibitors for cancer treatment: strategies for patient monitoring and management of immune-mediated adverse events ImmunoTargets and Therapy. 2017;Volume 6:51-71 Immune-Related Adverse Events with Immune Checkpoint Inhibitors: Polymyalgia Rheumatica Rheumatic Diseases and Syndromes Induced by Cancer Immunotherapy. 2021;89-98 Mechanisms of immune-related adverse events during the treatment of cancer with immune checkpoint inhibitors Rheumatology. 2019;58(Supplement_7):vii59-vii67 Editorial: Management of Immune-Related Adverse Events for Patients Undergoing Treatment With Checkpoint Inhibitors Frontiers in Oncology. 2019;9: Clinical Characteristics and Treatment of Immune-Related Adverse Events of Immune Checkpoint Inhibitors Immune Network. 2020;20(1): Spectrum and Management of Immune Related Adverse Events Due to Immune Checkpoint Inhibitors Current Cancer Research. 2021;139-173 Incidence and Management of Immune-Related Adverse Events in Patients Undergoing Treatment with Immune Checkpoint Inhibitors Current Oncology Reports. 2018;20(3): MASCC 2020 recommendations for the management of immune-related adverse events of patients undergoing treatment with immune checkpoint inhibitors Supportive Care in Cancer. 2020;28(12):6107-6110 Immune-Related Adverse Events with Immune Checkpoint Inhibitors: Arthritis Rheumatic Diseases and Syndromes Induced by Cancer Immunotherapy. 2021;71-87 |
